150 related articles for article (PubMed ID: 24767713)
21. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Yokoyama S; Woods SL; Boyle GM; Aoude LG; MacGregor S; Zismann V; Gartside M; Cust AE; Haq R; Harland M; Taylor JC; Duffy DL; Holohan K; Dutton-Regester K; Palmer JM; Bonazzi V; Stark MS; Symmons J; Law MH; Schmidt C; Lanagan C; O'Connor L; Holland EA; Schmid H; Maskiell JA; Jetann J; Ferguson M; Jenkins MA; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Whiteman DC; Pharoah PD; Easton DF; Dunning AM; Newton-Bishop JA; Montgomery GW; Martin NG; Mann GJ; Bishop DT; Tsao H; Trent JM; Fisher DE; Hayward NK; Brown KM
Nature; 2011 Nov; 480(7375):99-103. PubMed ID: 22080950
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
23. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
24. MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.
Berwick M; MacArthur J; Orlow I; Kanetsky P; Begg CB; Luo L; Reiner A; Sharma A; Armstrong BK; Kricker A; Cust AE; Marrett LD; Gruber SB; Anton-Culver H; Zanetti R; Rosso S; Gallagher RP; Dwyer T; Venn A; Busam K; From L; White K; Thomas NE;
Pigment Cell Melanoma Res; 2014 May; 27(3):485-8. PubMed ID: 24406078
[TBL] [Abstract][Full Text] [Related]
25. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.
Steffen J; Varon R; Mosor M; Maneva G; Maurer M; Stumm M; Nowakowska D; Rubach M; Kosakowska E; Ruka W; Nowecki Z; Rutkowski P; Demkow T; Sadowska M; Bidziński M; Gawrychowski K; Sperling K
Int J Cancer; 2004 Aug; 111(1):67-71. PubMed ID: 15185344
[TBL] [Abstract][Full Text] [Related]
26. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
27. MITF E318K: A rare homozygous case with multiple primary melanoma.
Wallingford CK; Maas EJ; Howard A; DeBortoli E; Bhanja D; Lee K; Mothershaw A; Jagirdar K; Willett R; Betz-Stablein B; Sturm RA; Soyer HP; McInerney-Leo AM
Pigment Cell Melanoma Res; 2024 Jan; 37(1):68-73. PubMed ID: 37635363
[TBL] [Abstract][Full Text] [Related]
28. [MITF: a genetic key to melanoma and renal cell carcinoma?].
Bertolotto C; Lesueur F; Bressac de Paillerets B
Med Sci (Paris); 2012 Mar; 28(3):258-61. PubMed ID: 22480646
[No Abstract] [Full Text] [Related]
29. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families.
Dong C; Hemminki K
Int J Cancer; 2001 Apr; 92(1):144-50. PubMed ID: 11279618
[TBL] [Abstract][Full Text] [Related]
30. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
McCredie M; Macfarlane GJ; Bell J; Coates M
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
[TBL] [Abstract][Full Text] [Related]
31. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.
Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Zdrojowy R; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Narod SA; Lubiński J
J Med Genet; 2006 Nov; 43(11):863-6. PubMed ID: 17085682
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma.
Lang M; Vocke CD; Ricketts CJ; Metwalli AR; Ball MW; Schmidt LS; Linehan WM
Urology; 2021 Mar; 149():89-97. PubMed ID: 33242557
[TBL] [Abstract][Full Text] [Related]
33. CDKN2A common variant and multi-organ cancer risk--a population-based study.
Debniak T; Scott RJ; Huzarski T; Byrski T; Rozmiarek A; Debniak B; Górski B; Cybulski C; Medrek K; Mierzejewski M; Masojc B; Matyjasik J; Złowocka E; Teodorczyk U; Lener M; Klujszo-Grabowska E; Nej-Wołosiak K; Jaworowska E; Oszutowska D; Szymańska A; Szymańska J; Castaneda J; van de Wetering T; Suchy J; Kurzawski G; Oszurek O; Narod S; Lubinski J
Int J Cancer; 2006 Jun; 118(12):3180-2. PubMed ID: 16395703
[TBL] [Abstract][Full Text] [Related]
34. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
[TBL] [Abstract][Full Text] [Related]
35. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
36. BRCA2 germline mutations in male breast cancer patients in the Polish population.
Kwiatkowska E; Teresiak M; Lamperska KM; Karczewska A; Breborowicz D; Stawicka M; Godlewski D; Krzyzosiak WJ; Mackiewicz A
Hum Mutat; 2001; 17(1):73. PubMed ID: 11139248
[TBL] [Abstract][Full Text] [Related]
37. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
[TBL] [Abstract][Full Text] [Related]
38. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
39. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
[TBL] [Abstract][Full Text] [Related]
40. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
